Advanced Enzyme Technologies Share Price Prediction 2027: Scenario Targets, Valuation and Technical Outlook
- October 9, 2026
- Posted by: Kunal Singla
- Category: Market
CMP Rs 270.05 (9 Oct 2026). 52W range Rs 251.95 to Rs 419.00. PE 17.28. 2027 base Rs 321, bull Rs 388.
Quick Answer
Advanced Enzyme Technologies share price prediction 2027 centres on a conservative case of Rs 294, a base case of Rs 321 and a bull case of Rs 388, against a current price of Rs 270.05. These targets scale today’s price by reported EPS growth at a constant PE multiple, so they rest on earnings the company has already delivered, not on broker forecasts. The base case implies 18.9% upside from today’s price. The daily technical setup reads bearish.
The Advanced Enzyme Technologies share price forecast comes down to earnings growth and the multiple investors pay for it, and the reported numbers give a measured answer. The stock trades at Rs 270.05 on NSE as of 9 October 2026, 35.5% below its 52-week high of Rs 419.00, after the company reported net profit of Rs 173.61 crore for FY26.
This Advanced Enzyme Technologies stock forecast 2027 builds conservative, base and bull scenarios from exchange-reported financials, shareholding data and daily price indicators, with every assumption shown.
Click Here – Get Free Investment Predictions
Advanced Enzyme Technologies Share Price Today and Key Data
The Advanced Enzyme Technologies share price today is Rs 270.05 on NSE, up 1.94% on the day. The market capitalisation stands at Rs 2,967 crore. Over the past year the price has fallen 12.8% from Rs 309.75. Every Advanced Enzyme Technologies stock forecast figure below starts from this price.
| Metric | Value |
|---|---|
| Company | Advanced Enzyme Technologies (ADVENZYMES) |
| Current Price | Rs 270.05 |
| 52-Week High | Rs 419.00 (11 May 2026) |
| 52-Week Low | Rs 251.95 (30 March 2026) |
| Market Cap | Rs 2,967 crore |
| PE Ratio | 17.28 |
| Industry PE | 37.59 |
| PB Ratio | 1.82 |
| EPS (TTM) | Rs 15.34 |
| Return on Equity | 10.34% |
| Debt to Equity | 0.02 |
| Dividend Yield | 2.02% |
| Book Value per Share | Rs 145.72 |
What Is the Advanced Enzyme Technologies Share Price Prediction for 2027?
The Advanced Enzyme Technologies share price prediction for 2027 is a conservative case of Rs 294, a base case of Rs 321 and a bull case of Rs 388. Against Rs 270.05, these imply 8.9% upside, 18.9% upside and 43.7% upside. They are model scenarios built from reported EPS growth, not broker targets.
| Scenario | EPS Growth Basis | EPS Estimate | PE Multiple | Implied Value | Upside vs Current Price |
|---|---|---|---|---|---|
| Conservative Case | Lower of FY26 growth (28.6%) and 4-year CAGR (9.0%) | Rs 16.72 (+9.0%) | Unchanged from today (price to EPS ratio kept constant) | Rs 294 | +8.9% |
| Base Case | Average of the two | Rs 18.22 (+18.8%) | Unchanged from today (price to EPS ratio kept constant) | Rs 321 | +18.9% |
| Bull Case | Higher of the two (capped at 25%) | Rs 19.18 (+25.0%) | Re-rated 15.0% toward industry PE of 37.59 (still at or below it) | Rs 388 | +43.7% |
Each target takes today’s price of Rs 270.05 and scales it by the EPS growth assumed for that case, which is the same as holding the PE multiple constant. The conservative case uses the lower of the FY26 EPS growth and the 4-year EPS CAGR, the base case uses their average and the bull case uses the higher figure. The bull case also re-rates the PE multiple toward the industry level, because the stock trades below it. Together they form the Advanced Enzyme Technologies target price range for the FY27 outlook over the next 12 months, and the range is not a point estimate.
Advanced Enzyme Technologies Share Price Forecast: What Has to Go Right by 2027
Each Advanced Enzyme Technologies target price below depends on a specific EPS outcome, and the text states that outcome next to the number.
Conservative Case for the Advanced Enzyme Technologies Share Price Target: Rs 294
Reaching Rs 294 needs EPS to rise 9.0% to Rs 16.72 while the stock keeps its current PE multiple. That follows the slower 4-year EPS CAGR of 9.0%.
Base Case for the Advanced Enzyme Technologies Share Price Target: Rs 321
Reaching Rs 321 needs EPS to rise 18.8% to Rs 18.22, the average of the FY26 growth rate and the 4-year CAGR. Net profit growth of -4.6% in Q1 FY27 is below that pace, so earnings need to speed up to reach this level.
Bull Case for the Advanced Enzyme Technologies Share Price Target: Rs 388
Reaching Rs 388 needs EPS to rise 25.0% to Rs 19.18 and the PE multiple to re-rate 15.0% toward the industry PE. That sits inside the 52-week range of Rs 251.95 to Rs 419.00. A daily close above the nearest resistance level of Rs 291.29 (Supertrend) would be the first technical confirmation.
Advanced Enzyme Technologies Financial Performance: Revenue, Profit and Margins
Advanced Enzyme Technologies earned net profit of Rs 173.61 crore on revenue of Rs 780.59 crore in FY26, with profit up 29.6% and revenue up 16.5% compared with FY25. Diluted EPS was Rs 15.06 against Rs 11.71 a year earlier, and that earnings base anchors the Advanced Enzyme Technologies share price forecast.
| Year | Revenue (Rs Cr) | Net Profit (Rs Cr) | EPS (Rs) | Operating Margin | Net Margin |
|---|---|---|---|---|---|
| FY22 | 535.80 | 123.80 | 10.68 | 39.48% | 23.11% |
| FY23 | 566.09 | 103.87 | 9.45 | 33.09% | 18.35% |
| FY24 | 660.53 | 136.95 | 11.92 | 36.41% | 20.73% |
| FY25 | 669.95 | 133.97 | 11.71 | 35.88% | 20.00% |
| FY26 | 780.59 | 173.61 | 15.06 | 37.06% | 22.24% |
In the latest reported quarter, Q1 FY27 (quarter ended June 2026), revenue was Rs 202.81 crore against Rs 194.76 crore a year earlier (+4.1%), and the bottom line was a net profit of Rs 38.59 crore against a net profit of Rs 40.44 crore (-4.6%). Operating margin was 33.72% versus 35.11% in the year-ago quarter. Cash flow from operations was Rs 156.78 crore in FY26 against Rs 142.50 crore in FY25. Together these figures set the earnings base for the Advanced Enzyme Technologies share price prediction.
Check the Univest Screener for live Advanced Enzyme Technologies fundamentals
Is Advanced Enzyme Technologies Overvalued or Undervalued Right Now?
Advanced Enzyme Technologies trades at a PE of 17.28 against an industry PE of 37.59, which places the stock at a 54.0% discount to the industry average. The price-to-book ratio is 1.82 on a book value of Rs 145.72 per share. Return on equity of 10.34% means the company earns Rs 10.34 of profit for every Rs 100 of shareholder equity.
Debt to equity is 0.02, so borrowings equal about 2% of shareholder equity. The company declared a dividend of Rs 5.35 per share for FY26, a yield of 2.02% at the current price. This valuation context frames the Advanced Enzyme Technologies stock price prediction for 2027 without relying on any outside forecast.
Advanced Enzyme Technologies Stock Analysis: Technical Outlook
Advanced Enzyme Technologies stock trades below its 50-day SMA of Rs 296.54 and below its 200-day EMA of Rs 311.45, and the combined daily indicators read bearish. The 52-week high of Rs 419.00 was set on 11 May 2026, while the 52-week low of Rs 251.95 came on 30 March 2026.
| Indicator | Reading | Signal |
|---|---|---|
| RSI (14) | 31.45 | Weak momentum |
| MACD (12,26,9) | -8.18 vs signal -6.63 | Bearish |
| ADX (14) | 28.21 | Established trend |
| Supertrend (10,3) | Price below Rs 291.29 | Bearish |
| 50-day SMA | Rs 296.54 | Price below |
| 200-day EMA | Rs 311.45 | Price below |
The nearest support level sits at Rs 251.95 (52-week low). The nearest resistance level sits at Rs 291.29 (Supertrend) and Rs 296.54 (50-day SMA). A sustained move above the nearest resistance would support the Advanced Enzyme Technologies share price prediction 2027 base case, and this Advanced Enzyme Technologies stock analysis uses daily candles only. Chart signals add context to the Advanced Enzyme Technologies share price target without changing the earnings maths.
Advanced Enzyme Technologies Shareholding Pattern
Promoters hold 43.24% of Advanced Enzyme Technologies as of Jun 2026, up from 43.08% in Jun 2025 across the last 5 quarters. FII holding is 26.71% (up from 23.46% in Jun 2025) and DII holding is 4.78% (down from 8.45% in Jun 2025), which puts combined institutional holding at 31.49%. Public shareholders own 25.27%. Shareholding data is one input for any Advanced Enzyme Technologies stock forecast. Ownership is a useful cross-check on any Advanced Enzyme Technologies share price prediction.
Key Risks to the Advanced Enzyme Technologies Share Price Target for 2027
Earnings and Margin Risk
Operating margin has ranged from 33.09% to 39.48% between FY22 and FY26, so a slip toward the lower end would trim the EPS estimate behind the Advanced Enzyme Technologies stock forecast. Revenue was up 16.5% in FY26, and slower revenue growth would weigh on the profit path.
Size and Liquidity Risk
Market capitalisation stands at Rs 2,967 crore. Investors should check daily traded volumes and order book depth on NSE before sizing a position, because price moves can be sharper when volumes thin out. Liquidity is a practical constraint on any Advanced Enzyme Technologies stock price target.
Balance Sheet Risk
Debt to equity of 0.02 means borrowings stand at about 2% of shareholder equity. A rise in borrowing costs or a jump in debt would weigh on profit and on the multiple behind the Advanced Enzyme Technologies share price forecast.
Technical Risk
The daily indicators read bearish, so the targets above may need a technical turn before the price follows earnings. A daily close below Rs 251.95 (52-week low) would weaken the setup further.
Conclusion
This Advanced Enzyme Technologies stock analysis puts the share price target range for 2027 at Rs 294 to Rs 388, with a base case of Rs 321 against Rs 270.05 today. The inputs are a PE of 17.28 that sits at a 54.0% discount to the industry average, EPS growth of 28.6% in FY26 and a daily technical setup that reads bearish. The next quarterly result will show which scenario is gaining ground. This analysis is educational, so consult a SEBI-registered advisor before acting on it.
Download the Univest iOS App or Univest Android App to track Advanced Enzyme Technologies live price and get daily stock recommendations.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on Advanced Enzyme Technologies Share Price Prediction 2027
What is the Advanced Enzyme Technologies share price target for 2027?
Ans. The Advanced Enzyme Technologies share price forecast for 2027 has a conservative case of Rs 294, a base case of Rs 321 and a bull case of Rs 388. These are model scenarios based on reported EPS growth, and they are not guaranteed outcomes.
What is the Advanced Enzyme Technologies share price today?
Ans. Advanced Enzyme Technologies trades at Rs 270.05 on NSE as of 9 October 2026, up 1.94% on the day. The 52-week range is Rs 251.95 to Rs 419.00.
Is Advanced Enzyme Technologies a good stock to buy for 2027?
Ans. The data points in different directions: the PE of 17.28 is at a 54.0% discount to the industry average, EPS grew 28.6% in FY26 and the daily technical setup reads bearish. This article does not constitute investment advice, so consult a SEBI-registered advisor before deciding.
Can Advanced Enzyme Technologies stock reach Rs 388 in 2027?
Ans. Reaching Rs 388 needs EPS to rise 25.0% from Rs 15.34 and the PE multiple to re-rate toward the industry PE of 37.59, plus a daily close above Rs 291.29 (Supertrend). This is a scenario, not a guarantee.
What are the support and resistance levels for Advanced Enzyme Technologies?
Ans. The nearest support levels are Rs 251.95 (52-week low), and the nearest resistance levels are Rs 291.29 (Supertrend) and Rs 296.54 (50-day SMA).
What are the main risks for Advanced Enzyme Technologies stock in 2027?
Ans. The main risks to the Advanced Enzyme Technologies share price forecast are a fall in operating margin from the 33.09% to 39.48% range seen since FY22, slower revenue growth after FY26 revenue was up 16.5%, and thin trading volumes. Debt to equity of 0.02 adds balance sheet sensitivity.
How is the Advanced Enzyme Technologies target price for 2027 calculated?
Ans. Each target scales the current price by assumed EPS growth at a constant PE multiple. The conservative case uses 9.0% growth, the base case 18.8% and the bull case 25.0%, all drawn from the company’s reported FY26 and 4-year EPS growth.
